Education
About Us
Working with TipRanks
Follow Us
Creo Medical Group PLC (GB:CREO)
LSE:CREO
Total Valuation
Creo Medical has a market cap or net worth of £52.59M. The enterprise value is 50.87M.
Market Cap£52.59M
Enterprise Value50.87M
Share Statistics
Creo Medical has 412,473,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding412,473,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Creo Medical’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -58.87%.
Return on Equity (ROE)-0.68
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)-58.87%
Return on Capital Employed (ROCE)-0.65
Revenue Per Employee14.39K
Profits Per Employee-100.00K
Employee Count278
Asset Turnover0.06
Inventory Turnover0.78
Valuation Ratios
The current PE Ratio of Creo Medical is 0.00. Creo Medical’s PEG ratio is -0.16.
PE Ratio0.00
PS Ratio0.00
PB Ratio1.14
Price to Fair Value0.00
Price to FCF-3.89
Price to Operating Cash Flow-3.53
PEG Ratio-0.16
Income Statement
In the last 12 months, Creo Medical had revenue of 4.00M and earned -28.70M in profits. Earnings per share was -0.08.
Revenue4.00M
Gross Profit1.90M
Operating Income-28.80M
Pretax Income-29.00M
Net Income-28.70M
EBITDA-26.10M
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was -20.10M and capital expenditures -1.30M, giving a free cash flow of -21.40M billion.
Operating Cash Flow-20.10M
Free Cash Flow-21.40M
Free Cash Flow per Share-0.05
Dividends & Yields
Creo Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.30
52-Week Price Change-61.07%
50-Day Moving Average12.70
200-Day Moving Average16.14
Relative Strength Index (RSI)42.71
Average Volume (3m)1.25M
Important Dates
Creo Medical upcoming earnings date is Oct 6, 2025, TBA (Not Confirmed).
Last Earnings DateMay 19, 2025
Next Earnings DateOct 6, 2025
Ex-Dividend Date―
Financial Position
Creo Medical as a current ratio of 2.75, with Debt / Equity ratio of 10.38%
Current Ratio2.75
Quick Ratio2.62
Debt to Market Cap0.00
Net Debt to EBITDA0.16
Interest Coverage Ratio-72.00
Taxes
In the past 12 months, Creo Medical has paid -1.20M in taxes.
Income Tax-1.20M
Effective Tax Rate0.04
Enterprise Valuation
Creo Medical EV to EBITDA ratio is 0.16, with an EV/FCF ratio of 0.19.
EV to Sales-1.07
EV to EBITDA0.16
EV to Free Cash Flow0.19
EV to Operating Cash Flow0.19
Balance Sheet
Creo Medical has £9.80M in cash and marketable securities with £14.20M in debt, giving a net cash position of £4.40M billion.
Cash & Marketable Securities£9.80M
Total Debt£14.20M
Net Cash£4.40M
Net Cash Per Share£0.01
Tangible Book Value Per Share£0.00
Margins
Gross margin is 49.50%, with operating margin of -720.00%, and net profit margin of -717.50%.
Gross Margin49.50%
Operating Margin-720.00%
Pretax Margin-725.00%
Net Profit Margin-717.50%
EBITDA Margin-652.50%
EBIT Margin-715.00%
Analyst Forecast
The average price target for Creo Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―